AUTOIMMUNITY part 73

Immune 4

 

INTRAVENOUS  IMMUNOGLOBULIN

Intravenous immunoglobulin (IVIG) is a preparation of human immunoglobulin pooled from thousands of healthy individuals. It was originally developed for replacement therapy in humoral immunodeficiency syndromes but has more recently become an important theurapetic modality in severe autoimmune disorders, such as thrombocytopenic purpura, AIHA, neuroimmunological diseases such as Guilland Barre syndrome, SLE, certain forms of vasculitis, and polymyositis/dermatomyositis. The mechanism of action remains unclear, but IVIG may block the function of Fc receptors expressed by phagocytes of the reticuloendothelial system and also induces FcγRIIB (inhibitory Fc receptor) expression on infiltrating macrophages in the K/BxN model of RA. An additional mode of action may involve the presence of anti-idiotypic antibodies that block the antigen combining sites of pathogenic antibodies. The duration of action is limited by the metabolism of serum immunoglobulin, and generally, IVIG is regarded as a temporary measure that is followed by modified tharapy.

Advertisements

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s